Account
Articles
18.06.2024
What does it take to secure access to digital heal...

Article originally published 11th August 2022, updated 18th June 2024. Introduction Digital health a...

Read more
Articles
11.06.2024
AI could transform diabetes management to improve ...

Article originally published 17th August 2022, updated 11th June 2024. Introduction Artificial intel...

Read more
Articles
05.06.2024
The impact of AI on drug pricing and reimbursement

Artificial intelligence is set to revolutionise the market access and healthcare landscape, but huma...

Read more
News
13.02.2024
World EPA Congress 2024

The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...

Read more
Articles
24.01.2024
What are the 5 Pricing & Market Access trends...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
Publications
25.10.2023
ISPOR Europe 2023: Evaluation and Reimbursement of...

Our study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...

Read more
Articles
01.06.2023
Digital health applications in EU5 market access

We explore the rapidly evolving market access landscape in respect to digital health applications in...

Read more
Articles
23.05.2023
How has the COVID-19 pandemic impacted the use of ...

Digital health technology played a vital role during the COVID-19 pandemic as there was a rapid usag...

Read more
News
17.05.2023
PMA Insights: Week 20 SPECIAL EDITION – ISPO...

We summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.